Name:

Diphtheria-Tetanus Vaccine

Abbreviation:

DT Vaccine

General Overview:

The diphtheria-tetanus vaccine is a combined inactivated (toxoid) vaccine used for the prevention of diphtheria and tetanus.

The vaccine contains diphtheria and tetanus toxoids – inactivated forms of bacterial toxins that stimulate the immune system without causing disease.

The vaccine is intended for children, especially in cases where there is a contraindication to the pertussis component or when the full course of pertussis vaccination has already been completed.

Storage Conditions:

• Store at +2°C to +8°C (in the refrigerator);
• Do not freeze, as freezing can damage the vaccine’s structure;
• Protect from direct light and sunlight;
• Before use, check the expiration date indicated on the packaging;

Significance and Effectiveness:

• Diphtheria and tetanus are life-threatening bacterial infections which, even with treatment, can result in severe complications, especially in children;
• DT vaccination significantly reduces the risk of transmission and complications of these diseases by producing a strong and long-lasting immune response to both diphtheria and tetanus toxoids;
• The vaccine has high effectiveness - in vaccinated children, the risk of developing diphtheria or tetanus is reduced by more than 90%;
• After completing the full vaccination schedule, long-term immunity is established, though booster doses are recommended at specific intervals to maintain protection;
• Vaccination also contributes to herd immunity, helping prevent the widespread transmission of these diseases in the community.